Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
-
2025
-
2026
March 2023 - 55 products
L
IP
Cabazitaxel Viatris 60
mg/3 ml
2447.84
2690.90
10 %
Infusionskonzentrat: Cabazitaxelum 60mg / 3ml
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 2,5 mg
30
5.36
15.05
10 %
Filmtabletten: Perindoprilum Argininum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 2,5 mg
90
15.83
33.60
10 %
Filmtabletten: Perindoprilum Argininum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 5 mg
30
7.66
17.55
10 %
Filmtabletten: Perindoprilum Argininum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 5 mg
90
15.98
33.80
10 %
Filmtabletten: Perindoprilum Argininum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 10 mg
30
9.55
26.75
10 %
Filmtabletten: Perindoprilum Argininum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Perindopril Arginin
Spirig HC 10 mg
90
18.70
36.75
10 %
Filmtabletten: Perindoprilum Argininum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 10 mg
10
5.02
14.85
10 %
Filmtabletten: Rivaroxabanum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 10 mg
30
15.05
33.10
10 %
Filmtabletten: Rivaroxabanum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 10 mg
98
51.65
73.70
10 %
Filmtabletten: Rivaroxabanum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 15 mg
14
7.21
24.40
10 %
Filmtabletten: Rivaroxabanum 15 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 15 mg
28
14.08
32.00
10 %
Filmtabletten: Rivaroxabanum 15 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 15 mg
98
51.65
73.70
10 %
Filmtabletten: Rivaroxabanum 15 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 20 mg
14
7.25
24.45
10 %
Filmtabletten: Rivaroxabanum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 20 mg
28
14.08
32.00
10 %
Filmtabletten: Rivaroxabanum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban Spirig HC 20 mg
98
51.65
73.70
10 %
Filmtabletten: Rivaroxabanum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban vascular
Spirig HC 2.5 mg
56
26.83
45.60
10 %
Filmtabletten: Rivaroxabanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Rivaroxaban vascular
Spirig HC 2.5 mg
196
93.92
118.55
10 %
Filmtabletten: Rivaroxabanum 2.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/500 mg
56
9.50
26.75
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/500 mg
196
33.27
52.60
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/850 mg
56
9.50
26.75
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/850 mg
196
33.27
52.60
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/1000mg
56
9.50
26.75
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
●
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Metformin
Zentiva 50/1000mg
196
33.27
52.60
10 %
Filmtabletten: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Alitretinoin Leman 10 mg
30
165.00
199.65
10 %
Weichkapseln: Alitretinoinum 10 mg
Leman SKL SA
A / SL / SG
FB
G
L
IP
CI
Alitretinoin Leman 30 mg
30
165.00
199.65
10 %
Weichkapseln: Alitretinoinum 30 mg
Leman SKL SA
A / SL / SG
FB
G
L
IP
CI
Aspaveli
2856.30
2971.60
10 %
Infusionslösung: Pegcetacoplanum 54 mg/ml
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
CI
Aspaveli
8
22850.40
23485.55
10 %
Infusionslösung: Pegcetacoplanum 54 mg/ml
Swedish Orphan
Biovitrum AG
A / SL
FB
G
IP
CI
ASS Cardio Zentiva 100 mg
30
1.85
11.25
10 %
Magensaftresistente Tabletten: Acidum Acetylsalicylicum 100 mg
Helvepharm AG
B / SL
FB
G
IP
CI
ASS Cardio Zentiva 100 mg
100
5.18
14.85
10 %
Magensaftresistente Tabletten: Acidum Acetylsalicylicum 100 mg
Helvepharm AG
B / SL
FB
G
L
IP
CI
Wegovy Multi FixDose 0.5 mg
147.61
176.95
10 %
Injektionslösung im Fertigpen: Semaglutidum
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Wegovy Multi FixDose 0.25 mg
147.61
176.95
10 %
Injektionslösung im Fertigpen: Semaglutidum
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Wegovy Multi FixDose 1 mg
147.61
176.95
10 %
Injektionslösung im Fertigpen: Semaglutidum 1mg / 0.75ml
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Wegovy Multi FixDose 1.7 mg
147.61
176.95
10 %
Injektionslösung im Fertigpen: Semaglutidum 1.7mg / 0.75ml
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Wegovy Multi FixDose 2.4 mg
147.61
176.95
10 %
Injektionslösung im Fertigpen: Semaglutidum 2.4mg / 0.75ml
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
Zepzelca 4 mg
+ +
5343.75
5790.50
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Lurbinectedinum 4 mg
PharmaMar AG
A / SL
FB
G
IP
Tranexamic OrPha 500 mg/5 ml
10
k.A.
Injektionslösung: Acidum Tranexamicum 500mg / 5ml
OrPha Swiss GmbH
B
FB
G
IP
Tranexamic OrPha 1000
mg/10 ml
10
k.A.
Injektionslösung: Acidum Tranexamicum 1000mg / 10ml
OrPha Swiss GmbH
B
FB
G
IP
Amoxicillin OrPha 250 mg
10
k.A.
Trockensubstanz: Amoxicillinum Anhydricum 250 mg
OrPha Swiss GmbH
A
FB
G
IP
Amoxicillin OrPha 500 mg
10
k.A.
Trockensubstanz: Amoxicillinum Anhydricum 500 mg
OrPha Swiss GmbH
A
FB
G
IP
Amoxicillin OrPha 1 g
10
k.A.
Trockensubstanz: Amoxicillinum Anhydricum 1 g
OrPha Swiss GmbH
A
FB
G
IP
Amoxicillin OrPha 2 g
10
k.A.
Trockensubstanz: Amoxicillinum Anhydricum 2 g
OrPha Swiss GmbH
A
FB
G
IP
CI
CM
Nasenspray Neo Spirig HC
0.05 %
10 ml
k.A.
Nasenspray: Xylometazolini Hydrochloridum
Spirig HealthCare AG
D
FB
G
IP
CI
CM
Nasenspray Neo Spirig HC 0.1 %
10 ml
k.A.
Nasenspray: Xylometazolini Hydrochloridum 1 mg/ml/ml
Spirig HealthCare AG
D
FB
G
IP
CI
Sara
21
k.A.
Filmtabletten: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Sara
3 x 21
k.A.
Filmtabletten: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Sara
6 x 21
k.A.
Filmtabletten: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Ulipristal Sandoz
k.A.
Filmtablette: Ulipristalii Acetas 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
neotylol Muco 600 mg
10
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen im Beutel: Acetylcysteinum 600 mg
NOBEL Pharma Schweiz AG
D
FB
G
IP
CI
Rectodelt
6
k.A.
Zäpfchen: Prednisonum 100 mg
Dermapharm AG
B
FB
G
IP
CI
CM
Fosfomycin Maddox 3 g
k.A.
Fosfomycinum 3 g
MADDOX Pharma Swiss
GmbH
A
FB
G
IP
Calrecia 100 mmol/l
8 x 1500 ml
k.A.
Infusionslösung: Calcii Chloridum Dihydricum
Fresenius Medical
Care (Schweiz) AG
B
FB
G
IP
CI
Rectodelt
2
k.A.
Zäpfchen: Prednisonum 100 mg
Dermapharm AG
B
FB
G
IP
CI
Rectodelt
4
k.A.
Zäpfchen: Prednisonum 100 mg
Dermapharm AG
B
FB
G
IP
Locametz 25 ug
k.A.
trousse pour préparation radiopharmaceutique: Gozetotidum 25 µg
Novartis Pharma
Schweiz AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
